tiprankstipranks
Trending News
More News >
Newmed Energy Limited Partnership (IL:NWMD)
:NWMD

Newmed Energ Pu (NWMD) AI Stock Analysis

Compare
5 Followers

Top Page

IL:NWMD

Newmed Energ Pu

(NWMD)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 4o)
Rating:80Outperform
Price Target:
2,022.00
▲(20.14% Upside)
Newmed Energ Pu demonstrates strong financial performance and technical indicators, with an attractive valuation. The company's operational efficiency and improved leverage position are significant strengths, while the recent revenue decline requires monitoring. The stock's upward trend and favorable P/E ratio enhance its investment appeal.
Positive Factors
Business Model Strength
The focus on renewable energy solutions positions Newmed Energ Pu well in a growing market, leveraging sustainable technologies to meet increasing demand for clean energy.
Partnerships and Market Reach
Strategic partnerships expand market access and facilitate large-scale projects, strengthening competitive positioning and driving long-term revenue growth.
Profitability and Margins
High profitability and margins indicate efficient operations and effective cost management, supporting sustainable financial performance over time.
Negative Factors
Revenue Growth Decline
A decline in revenue growth could signal challenges in market expansion or competition, potentially impacting future earnings and strategic initiatives.
High Debt Levels
High leverage can limit financial flexibility and increase risk during economic downturns, affecting the company's ability to invest and grow.
Free Cash Flow Decline
Decreasing free cash flow growth may hinder the company's capacity to fund new projects and investments, impacting long-term strategic goals.

Newmed Energ Pu (NWMD) vs. iShares MSCI Israel ETF (EIS)

Newmed Energ Pu Business Overview & Revenue Model

Company DescriptionNewMed Energy - Limited Partnership engages in the exploration, development, production, and sale of petroleum, natural gas, and condensate in Israel and Cyprus. The company holds interests in the Leviathan project, which covers an area of 500 square kilometer (km2) located to the west of the shores of Haifa; the Block 12 that covers an area of approximately 386 km2 located in Cyprus; and the Yam Tethys project, which covers an area of approximately 500 km2 located to the west of the shores of Ashkelon. It also holds interests in the Boujdour Atlantique exploration license that covers an area of approximately 33,812 km2 located in the south of the Moroccan exclusive economic zone; and the Tanin and Karish leases covering an area of approximately 500km2 located to the west of the shores of Nahariya. The company serves independent power producers, marketing companies, and industrial customers, as well as exports natural gas to Jordan and in Egypt. NewMed Energy Management Ltd. serves as the general partner of the company. The company was formerly known as Delek Drilling - Limited Partnership and changed its name to NewMed Energy - Limited Partnership in February 2022. NewMed Energy - Limited Partnership was incorporated in 1993 and is based in Herzliya, Israel. NewMed Energy - Limited Partnership is a subsidiary of Delek Energy Systems Ltd.
How the Company Makes MoneyNewmed Energ Pu generates revenue through multiple streams, including the sale and installation of renewable energy systems, maintenance services for existing installations, and consultancy services in energy efficiency. Additionally, the company benefits from government incentives and subsidies aimed at promoting renewable energy adoption. Significant partnerships with technology providers and local governments enhance NWMD's market reach and contribute to its earnings by facilitating large-scale projects and ensuring compliance with regulatory standards.

Newmed Energ Pu Financial Statement Overview

Summary
Newmed Energ Pu is financially robust with strong profitability and cash flow generation. While the recent revenue decline warrants attention, the company’s operational efficiency and improved leverage position provide a solid foundation for future growth.
Income Statement
75
Positive
Newmed Energ Pu demonstrates strong profitability with high gross and net profit margins, indicating efficient cost management. However, the recent TTM revenue shows a decline, which could be a concern if the trend continues. Despite this, the company maintains robust EBIT and EBITDA margins, reflecting operational efficiency.
Balance Sheet
70
Positive
The company has improved its debt-to-equity ratio over recent periods, indicating better leverage management. Return on equity remains strong, showcasing effective use of equity to generate profits. However, the equity ratio suggests moderate reliance on debt, which could pose risks if market conditions worsen.
Cash Flow
80
Positive
Newmed Energ Pu shows a healthy cash flow position with positive free cash flow growth and a strong operating cash flow to net income ratio. The company effectively converts its earnings into cash, which supports its financial flexibility and ability to invest in growth opportunities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.02B1.14B934.60M1.14B882.50M587.10M
Gross Profit628.70M718.10M780.70M701.70M518.11M535.48M
EBITDA747.20M874.80M782.70M872.10M657.20M524.20M
Net Income445.60M524.60M433.60M469.70M404.90M365.30M
Balance Sheet
Total Assets3.95B3.99B3.85B3.94B3.85B4.58B
Cash, Cash Equivalents and Short-Term Investments240.30M384.50M186.70M418.30M340.85M239.35M
Total Debt1.42B1.63B1.82B2.16B2.22B3.25B
Total Liabilities2.02B2.21B2.33B2.65B2.91B3.59B
Stockholders Equity1.93B1.79B1.51B1.29B938.54M997.70M
Cash Flow
Free Cash Flow330.50M463.30M423.10M405.80M423.25M163.59M
Operating Cash Flow514.10M577.50M559.50M504.70M453.64M328.68M
Investing Cash Flow47.30M-114.20M36.10M-273.50M982.04M-241.82M
Financing Cash Flow-524.40M-441.20M-588.90M-429.10M-1.29B-187.92M

Newmed Energ Pu Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1683.00
Price Trends
50DMA
1673.16
Negative
100DMA
1616.01
Positive
200DMA
1489.17
Positive
Market Momentum
MACD
3.10
Negative
RSI
50.18
Neutral
STOCH
49.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Neutral. The current price of 1683 is above the 20-day moving average (MA) of 1676.07, above the 50-day MA of 1673.16, and above the 200-day MA of 1489.17, indicating a neutral trend. The MACD of 3.10 indicates Negative momentum. The RSI at 50.18 is Neutral, neither overbought nor oversold. The STOCH value of 49.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$19.34B12.2024.33%4.25%-15.01%-16.12%
77
Outperform
$5.28B10.9727.38%9.15%-15.49%-8.29%
76
Outperform
$16.33B17.524.49%6.59%17.71%211.99%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
60
Neutral
3.03B21.117.32%5.30%-23.48%
44
Neutral
13.20B69.61%-282.20%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:NWMD
Newmed Energ Pu
1,683.00
581.57
52.80%
IL:DLEKG
Delek Group
85,750.00
42,317.90
97.43%
IL:ISRA
Isramco Pu
238.50
62.80
35.74%
IL:RATI
Ratio Pu
447.00
125.45
39.01%
IL:TMRP
Tamar Pet
3,805.00
1,601.71
72.70%
IL:NVPT
Navitas Ptro Pu
12,000.00
5,130.00
74.67%

Newmed Energ Pu Corporate Events

NewMed Energy Reports Earnings and Strategic Developments
Nov 18, 2025

NewMed Energy Limited Partnership is a company engaged in the exploration, development, production, and marketing of natural gas, condensate, and oil, primarily operating in Israel, Cyprus, Bulgaria, and Morocco, with interests in renewable energy projects.

NewMed Energy Reports Q2 Earnings Amid Operational Challenges
Aug 20, 2025

NewMed Energy Limited Partnership is a company primarily engaged in the exploration, development, production, and marketing of natural gas, condensate, and oil, operating in Israel, Cyprus, Bulgaria, and Morocco, with a focus on increasing natural gas sales and exploring renewable energy opportunities. In its latest earnings report, NewMed Energy announced a profit distribution of $60 million and highlighted the impact of military operations in Q2 2025, which led to a temporary halt in natural gas production from the Leviathan reservoir. The company’s comprehensive income for the period was $197.4 million, a decrease of 23.5% compared to the previous year, mainly due to reduced revenues from natural gas and condensate sales. Despite the challenges, NewMed Energy continued to secure new agreements for natural gas supply, including deals with Jordan and Egypt, and maintained its credit ratings, reflecting resilience amid geopolitical tensions. Looking forward, the company remains focused on resuming full production and exploring additional opportunities in renewable energy and hydrogen projects, while navigating the uncertainties posed by regional conflicts.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025